Process characterization strategy for a precipitation step for host cell protein reduction.

Area of Science:

• Biopharmaceutical Process Development
• Chemical Engineering
• Quality by Design (QbD)

Background:

• Precipitation steps are crucial for impurity removal in biopharmaceutical manufacturing.
• Quality by Design (QbD) approaches are rarely applied to precipitation steps for process characterization.
• Efficient characterization strategies are needed for optimizing these critical steps.

Purpose of the Study:

• To propose and demonstrate a streamlined, two-step QbD approach for characterizing precipitation steps.
• To optimize host cell protein (HCP) removal during monoclonal antibody purification using sodium caprylate precipitation.
• To establish a robust operating space for the precipitation step.

Main Methods:

• A two-step characterization strategy focusing on product quality and process performance.
• Risk assessment for methodical selection of process parameters based on literature and prior data.
• Multivariate experimental design to decouple product quality and process performance impacts.
• Linkage studies to demonstrate robustness across the overall purification process.

Main Results:

• The proposed QbD approach efficiently characterized the sodium caprylate precipitation step.
• Robust HCP reduction to ≤100 ppm was achieved within a defined operating space (≤1% sodium caprylate, pH 5.0-6.0, filter flux ≤300 L/m²-hr).
• The strategy proved effective even with high initial HCP concentrations (up to 19,000 ppm).

Conclusions:

• The two-step QbD approach offers an efficient and streamlined strategy for precipitation step characterization.
• This method allows for tailored experimental design, manageable experiments, and reduced resource consumption.
• The established operating space ensures robust HCP removal and drug substance quality.